To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to ...

It is a highly customized therapy in which cancer-fighting T-cells are drawn directly from the blood of a patient and given ...

Lurie Comprehensive Cancer Center of Northwestern University ... early steps of interactions between the cytoskeleton and E-cadherin, the cellular "glue" protein. They found that before cells make ...

Northwestern Medicine investigators have uncovered new insights into how intercellular "glue" functions to enable interactions between cells ... the cytoskeleton and E-cadherin, the cellular ...

Once reintroduced back into the body, the T cells replicate, creating a surge of cancer-fighting immune cells. The results of Vitanza’s early-stage clinical trial were published in Nature ...

The CAR-T cell therapy was tested on patients with B-cell leukaemia and lymphoma - rare types of blood cancers - that affect the bone marrow and the lymphatic system. Listen to Story India's first Car ...

Scientists have turned the same immune response that rejects organ transplants to their advantage – to target cancer. In a trailblazing fusion of immunology and ingenuity, a team of Chinese ...

"If we had the ability to have more potential early detection, then we could see abnormalities in cells … before it actually gets to cancer and could take the time to address it ...

Time-lapse video of competition within patient-derived metaplastic cancer cells ... caused by variations in E-cadherin adhesion strength, shaping the dynamics of cell competition.

The junction protein E-cadherin plays a significant role in the intercellular force transmission in epithelia. It contributes to cells attaching themselves ... acute inflammation and even cancer.” ...

The junction protein E-cadherin plays a significant role in the intercellular force transmission in epithelia. It contributes to cells attaching themselves to each other (cell adhesions ...